[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80827]], camposKey:0365-6691 2023-10-01 Detecting progression of acute zonal occult outer retinopathy (AZOOR) with optical coherence tomography angiography: A case report Detección de la progresión de la retinopatía externa oculta zonal aguda (AZOOR) con angiografía por tomografía de coherencia óptica: a propósito de un caso595600, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80983]], camposKey:0392-856X 2023-10-01 Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study21052114, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81334]], camposKey:0365-6691 2023-01-01 Detección de la progresión de la retinopatía externa oculta zonal aguda (AZOOR) con angiografía por tomografía de coherencia óptica: a propósito de un caso595600, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75394]], camposKey:2077-0383 2022-12-01 Tear and Plasma Levels of Cytokines in Patients with Uveitis: Search for Active Disease Biomarkers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75395]], camposKey:2044-6055 2022-03-22 Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: A protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69948]], camposKey:0365-6691 2022-01-01 Caso clínico: coroiditis serpiginosa-like con afectación macular y buena evolución tras tratamiento con adalimumab477480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42322]], camposKey:0165-5701 2019-01-15 Vision-threatening bilateral panuveitis and TRAPS in a child: an uncommon association219223, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3529]], camposKey:0146-0404 2017-01-01 Prehematopoietic stem cell transplantation tear cytokines as potential susceptibility biomarkers for ocular chronic graft-versus-host disease48364846, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68533]], camposKey:0007-1161 2016-08-01 Scleritis in patients with granulomatosis with polyangiitis (Wegener)10621065, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68534]], camposKey:0002-9394 2016-04-01 Rituximab in the Treatment of Refractory Noninfectious Scleritis2228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3543]], camposKey:0146-0404 2016-01-01 Biomarkers in ocular chronic graft versus host disease: Tear cytokine- and chemokine-based predictive model746758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68535]], camposKey:1746-9899 2015-08-01 Are patients being treated with immunosuppression for ocular inflammatory disease adequately?341350, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3547]], camposKey:0146-0404 2015-01-01 Gene expression-based predictive models of graft versus host disease-associated dry eye45704581][][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=122824],camposKey=8494531522El síndrome de ojo seco y su manejo 1 2016-01-01 You and Us}][][][][][][][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@371b03a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7eebd64c][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64e24d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64f2e5][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5ba283]][][][][][][][]